Common Fungal Infection Deadly for Lung Disease Patients, AIIMS Study Finds
Deadly Fungal Infection Threatens Lung Disease Patients
Study Reveals High Mortality Rate for Chronic Pulmonary Aspergillosis
A new study has shed light on the deadly threat posed by chronic pulmonary aspergillosis (CPA), a fungal infection that claims hundreds of thousands of lives globally each year. Researchers at the All India Institute of Medical Sciences (AIIMS) in new Delhi found that CPA can be fatal for a notable portion of individuals with pre-existing lung conditions.
The study, published in the prestigious journal Lancet Infectious Diseases, analyzed data from over 8,700 patients worldwide. The findings paint a stark picture: approximately 32% of individuals with prior lung damage who contract CPA will succumb to the infection within five years.
“This is a serious public health concern,” said Dr. Abinhav Sengupta, a lead researcher on the study. “CPA can be especially devastating for those already struggling with lung diseases.”
CPA is caused by inhaling spores of the Aspergillus mold, which is commonly found in the environment. While exposure is generally harmless for healthy individuals, those with weakened lungs are more susceptible. The infection leads to gradual scarring of the lungs, resulting in debilitating symptoms such as fatigue, weight loss, shortness of breath, and coughing up blood.
The study also highlighted a concerning trend: CPA is often misdiagnosed as tuberculosis (TB), leading to delayed treatment.
“This is a critical issue,” explained Dr. Animesh Ray,another researcher involved in the study. “CPA requires antifungal medication or surgery, which are not effective against TB. Misdiagnosis can have fatal consequences.”
The researchers emphasized the importance of early detection and appropriate treatment for CPA. Antifungal drugs and surgical interventions can significantly improve symptoms and reduce the risk of death.
The study serves as a crucial reminder of the hidden dangers posed by fungal infections, particularly for vulnerable populations with pre-existing lung conditions.Increased awareness among healthcare professionals and the public is essential to ensure timely diagnosis and treatment, ultimately saving lives.
Silent Threat: Deadly Fungal Infection Devastates Lung Disease Patients
New Delhi, India – A groundbreaking study published in the esteemed journal Lancet Infectious Diseases has sounded the alarm on a deadly fungal infection silently claiming the lives of hundreds of thousands worldwide: chronic pulmonary aspergillosis (CPA).
Conducted by researchers at the All India Institute of Medical Sciences (AIIMS), the study analyzed data from over 8,700 patients internationally, revealing a chilling statistic: 32% of individuals with pre-existing lung conditions who contract CPA will succumb to the infection within five years.
“This is a serious public health concern,” stated Dr. abinhav Sengupta, a leading researcher on the study. “CPA can be especially devastating for those already battling lung diseases.”
Caused by inhalation of Aspergillus mold spores, commonly found in the environment, CPA primarily affects individuals with weakened lungs. Infection leads to gradual lung scarring, manifesting in debilitating symptoms such as fatigue, weight loss, shortness of breath, and coughing up blood.
Adding to the danger, CPA is frequently misdiagnosed as tuberculosis (TB), leading to possibly fatal delays in treatment. “CPA requires antifungal medication or surgery, treatments ineffective against TB,” explains Dr. Animesh Ray, another researcher involved in the study. “Misdiagnosis can have devastating consequences.”
The research team stresses the urgency of early CPA detection and appropriate treatment. Antifungal drugs and surgical interventions can significantly improve symptoms and reduce mortality risk.
This study serves as a critical call to action, underscoring the hidden dangers of fungal infections, especially for vulnerable populations with pre-existing lung conditions. Increased awareness among healthcare professionals and the public is essential for ensuring timely diagnosis and treatment,ultimately saving lives.